Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA